Literature DB >> 28259685

Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation.

Mrinal K Sarkar1, Nihal Kaplan2, Lam C Tsoi3, Xianying Xing1, Yun Liang1, William R Swindell1, Paul Hoover2, Maya Aravind1, Gleb Baida2, Matthew Clark1, John J Voorhees1, Rajan P Nair1, James T Elder1, Irina Budunova2, Spiro Getsios2, Johann E Gudjonsson4.   

Abstract

The factors involved in maintaining a localized inflammatory state in psoriatic skin remain poorly understood. Here, we demonstrate through metabolomic and transcriptomic profiling marked suppression of glucocorticoid biosynthesis in the epidermis of psoriatic skin leading to localized deficiency of cortisol. Utilizing a 3D human epidermis model, we demonstrate that glucocorticoid biosynthesis is suppressed by proinflammatory cytokines and that glucocorticoid deficiency promotes inflammatory responses in keratinocytes. Finally, we show in vitro and in vivo that treatment with topical glucocorticoids leads to rapid restoration of glucocorticoid biosynthesis gene expression coincident with normalization of epidermal differentiation and suppression of inflammatory responses. Taken together, our data suggest that localized glucocorticoid deficiency in psoriatic skin interferes with epidermal differentiation and promotes a sustained and localized inflammatory response. This may shed new light on the mechanism of action of topical steroids, and demonstrates the critical role of endogenous steroid in maintaining both inflammatory and differentiation homeostasis in the epidermis.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28259685      PMCID: PMC5545780          DOI: 10.1016/j.jid.2017.02.972

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  42 in total

1.  Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?

Authors:  U Mrowietz; S Domm
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-07-25       Impact factor: 6.166

2.  Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes.

Authors:  Andrzej Slominski; Jacobo Wortsman; Mark F Foecking; Cedric Shackleton; Celso Gomez-Sanchez; Andre Szczesniewski
Journal:  J Invest Dermatol       Date:  2002-02       Impact factor: 8.551

3.  Abnormal maturation pathway of keratinocytes in psoriatic skin.

Authors:  B A Bernard; S M Robinson; S Vandaele; J N Mansbridge; M Darmon
Journal:  Br J Dermatol       Date:  1985-06       Impact factor: 9.302

4.  A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.

Authors:  Andrzej Slominski; Jordan Zjawiony; Jacobo Wortsman; Igor Semak; Jeremy Stewart; Alexander Pisarchik; Trevor Sweatman; Josep Marcos; Chuck Dunbar; Robert C Tuckey
Journal:  Eur J Biochem       Date:  2004-11

Review 5.  Immunology of psoriasis.

Authors:  Michelle A Lowes; Mayte Suárez-Fariñas; James G Krueger
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 6.  Cross-Disease Transcriptomics: Unique IL-17A Signaling in Psoriasis Lesions and an Autoimmune PBMC Signature.

Authors:  William R Swindell; Mrinal K Sarkar; Yun Liang; Xianying Xing; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2016-05-17       Impact factor: 8.551

Review 7.  New dimension of glucocorticoids in cancer treatment.

Authors:  Kai-Ti Lin; Lu-Hai Wang
Journal:  Steroids       Date:  2016-02-27       Impact factor: 2.668

8.  In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones.

Authors:  F Atzeni; P Sarzi-Puttini; S DePortu; M Cutolo; M Carrabba; R H Straub
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

Review 9.  Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor.

Authors:  Andrew R Clark; Maria G Belvisi
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

10.  Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes.

Authors:  Ali Jabbari; Mayte Suárez-Fariñas; Scott Dewell; James G Krueger
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

View more
  20 in total

1.  Adalimumab in Psoriasis: How Much Is Enough?

Authors:  Allison C Billi; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2019-01       Impact factor: 8.551

2.  Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis.

Authors:  Wei Wang; Gao-Feng Shu; Kong-Jun Lu; Xiao-Ling Xu; Min-Cheng Sun; Jing Qi; Qiao-Ling Huang; Wei-Qiang Tan; Yong-Zhong Du
Journal:  J Nanobiotechnology       Date:  2020-05-24       Impact factor: 10.435

Review 3.  How UV Light Touches the Brain and Endocrine System Through Skin, and Why.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Przemyslaw M Plonka; Jerzy P Szaflarski; Ralf Paus
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

Review 4.  Psoriasis: Past, Present, and Future.

Authors:  Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal:  J Invest Dermatol       Date:  2019-11       Impact factor: 8.551

Review 5.  Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives.

Authors:  Shirin Kahremany; Lukas Hofmann; Marco Harari; Arie Gruzman; Guy Cohen
Journal:  Pharmacol Rep       Date:  2021-01-18       Impact factor: 3.024

6.  Transcriptomic Network Interactions in Human Skin Treated with Topical Glucocorticoid Clobetasol Propionate.

Authors:  Loukia N Lili; Anna Klopot; Benjamin Readhead; Gleb Baida; Joel T Dudley; Irina Budunova
Journal:  J Invest Dermatol       Date:  2019-06-25       Impact factor: 8.551

7.  A Poly (Caprolactone)-Cellulose Nanocomposite Hydrogel for Transdermal Delivery of Hydrocortisone in Treating Psoriasis Vulgaris.

Authors:  Pierre P D Kondiah; Thankhoe A Rants'o; Sipho Mdanda; Lauwrence M Mohlomi; Yahya E Choonara
Journal:  Polymers (Basel)       Date:  2022-06-28       Impact factor: 4.967

8.  The significance of CYP11A1 expression in skin physiology and pathology.

Authors:  R M Slominski; C Raman; C Elmets; A M Jetten; A T Slominski; R C Tuckey
Journal:  Mol Cell Endocrinol       Date:  2021-03-12       Impact factor: 4.369

9.  Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation.

Authors:  Judit Bigas; Lisa M Sevilla; Elena Carceller; Julia Boix; Paloma Pérez
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

Review 10.  The Extracellular Matrix in Skin Inflammation and Infection.

Authors:  Karin Pfisterer; Lisa E Shaw; Dörte Symmank; Wolfgang Weninger
Journal:  Front Cell Dev Biol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.